PLAINS ALL AMERICAN PIPELINE LP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $726.0m $856.0m $2.2b $2.2b ($2.6b) $593.0m $1.0b $1.2b $772.0m $1.4b
Cash used in investing activities - continuing operations ($1.3b) ($540.0m) ($1.3b) ($3.6b)
Cash used in investing activities - discontinued operations ($162.0m) ($170.0m) ($197.0m)
Effect of translation adjustment - continuing operations $4.0m ($9.0m) ($3.0m) ($8.0m) ($5.0m) ($3.0m) $3.0m ($11.0m) $14.0m
Effect of translation adjustment - discontinued operations ($3.0m) $2.0m $0
Income from discontinued operations, net of tax ($192.0m) ($231.0m) ($383.0m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($192.0m) ($231.0m) $1.1b
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($192.0m) ($231.0m) $1.4b
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($192.0m) ($231.0m) $383.0m
Net Income (Loss) Attributable to Noncontrolling Interest $4.0m $2.0m $0 $9.0m $10.0m $55.0m $191.0m $272.0m $341.0m $334.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $730.0m $858.0m $2.2b $2.2b ($2.6b) $648.0m $1.2b $1.5b $1.1b $1.8b
Amortization of Intangible Assets $44.0m $54.0m $66.0m $76.0m $90.0m $122.0m $254.0m $308.0m $266.0m $280.0m
Depreciation $470.0m $463.0m $454.0m $525.0m $563.0m $652.0m $707.0m $733.0m $753.0m $673.0m
Depreciation, Depletion and Amortization $494.0m $626.0m $520.0m $601.0m $653.0m $774.0m $965.0m $1.0b $1.0b $953.0m
Deferred Income Tax Expense (Benefit) ($60.0m) $16.0m $132.0m ($46.0m) ($70.0m) $23.0m $105.0m ($24.0m) ($28.0m) $14.0m
(Gains)/losses on asset sales, asset impairments and other, net (Note 7, Note 8) ($20.0m) $109.0m ($114.0m) $28.0m $719.0m $592.0m $269.0m ($152.0m) $160.0m ($54.0m)
Gain (Loss) on Sale of Assets and Asset Impairment Charges $114.0m ($28.0m) ($719.0m) ($592.0m) ($269.0m) $152.0m ($160.0m) $54.0m
Goodwill, Impairment Loss $2.5b $0 $0
Share-based Payment Arrangement, Expense $60.0m $41.0m $79.0m $34.0m $15.0m $23.0m $40.0m $50.0m $50.0m $49.0m
Equity Method Investment, Realized Gain (Loss) on Disposal $200.0m
Income (Loss) from Equity Method Investments $195.0m $290.0m $375.0m $388.0m $355.0m $274.0m $403.0m $369.0m $452.0m $382.0m
Income Tax Expense (Benefit) $25.0m $44.0m $198.0m $66.0m ($19.0m) $73.0m $189.0m $121.0m $167.0m $15.0m
Interest Expense Nonoperating $430.0m $554.0m
Operating Lease, Lease Income $28.0m $29.0m $32.0m $26.0m $8.0m
Other Nonoperating Income (Expense) $33.0m ($31.0m) ($7.0m) $24.0m $39.0m $19.0m ($219.0m) $102.0m $65.0m $108.0m
Changes in operating assets and liabilities:
Additional Financial Items
(Gain)/loss on foreign currency revaluation ($16.0m) ($7.0m) $41.0m $8.0m ($17.0m) $13.0m
Asset Retirement Obligation, Accretion Expense $4.0m $5.0m $5.0m $4.0m $4.0m $4.0m $4.0m $4.0m
Borrowing under term loan (Note 11) $0 $0 $1.1b
Cash paid for purchases of linefill ($14.0m) ($37.0m) ($84.0m) ($23.0m) ($21.0m) ($27.0m)
Cash paid in connection with acquisitions, net of cash acquired (Note 8) ($282.0m) ($1.3b) $0 ($50.0m) ($310.0m) ($32.0m) ($149.0m) ($425.0m) ($248.0m) ($2.7b)
Change in fair value of Preferred Distribution Rate Reset Option (Note 13) ($30.0m) ($13.0m) $14.0m ($20.0m) ($14.0m) $189.0m ($58.0m) $0 $0
Distributions on earnings from unconsolidated entities $216.0m $304.0m $422.0m $401.0m $472.0m $431.0m $488.0m $458.0m $505.0m $486.0m
Distributions paid to unitholders (Note 12) ($1.1b) ($1.4b) ($1.0b) ($1.2b) ($853.0m) ($715.0m) ($782.0m) ($989.0m) ($1.1b) ($1.3b)
Equity earnings in unconsolidated entities ($195.0m) ($290.0m) ($375.0m) ($388.0m) ($355.0m) ($274.0m) ($403.0m) ($369.0m) ($452.0m) ($382.0m)
Equity-indexed compensation expense $60.0m $41.0m $79.0m $34.0m $15.0m $23.0m $40.0m $50.0m $50.0m $49.0m
Foreign Currency Transaction Gain (Loss), before Tax ($8.0m) $21.0m $1.0m $1.0m $16.0m $7.0m ($41.0m) ($8.0m) $17.0m ($13.0m)
Gain on investments in unconsolidated entities, net (Note 8, Note 9) ($2.0m) ($346.0m) ($28.0m) ($15.0m) ($31.0m)
General and Administrative Expense $279.0m $276.0m $316.0m $297.0m $271.0m $292.0m $325.0m $350.0m $381.0m $342.0m
Goodwill $2.3b $2.6b $2.5b $2.5b $0
Income taxes, net of amounts refunded (Note 15) $98.0m $50.0m $21.0m $136.0m $111.0m $76.0m $112.0m $69.0m $269.0m $98.0m
Increase (Decrease) in Inventories $463.0m ($605.0m) $75.0m $5.0m $304.0m $18.0m $10.0m ($223.0m) ($70.0m) ($96.0m)
Interest, net of amounts capitalized $450.0m $486.0m $400.0m $397.0m $428.0m $401.0m $393.0m $377.0m $381.0m $516.0m
Inventory ($463.0m) $605.0m ($75.0m) ($5.0m) ($304.0m) ($18.0m) ($10.0m) $223.0m $70.0m $96.0m
Inventory Write-down $3.0m $35.0m $8.0m $11.0m $233.0m $0 $0 $0 $0 $0
Investments in related party notes (Note 17) $0 ($629.0m) ($330.0m)
Investments in unconsolidated entities (Note 9) ($301.0m) ($416.0m) ($468.0m) ($524.0m) ($461.0m) ($94.0m) ($14.0m) ($33.0m) ($4.0m) ($2.0m)
Net borrowings/(repayments) under commercial paper program (Note 11) ($564.0m) ($690.0m) ($123.0m) $93.0m $456.0m ($545.0m) $433.0m ($40.0m) $577.0m
Operating Costs and Expenses $1.2b $1.2b $1.3b $1.3b $1.1b $1.1b $1.3b $1.4b $1.8b $1.2b
Other $23.0m $10.0m $25.0m $21.0m ($12.0m) $8.0m $16.0m $20.0m $17.0m $15.0m
Proceeds from Contributions from Affiliates $42.0m
Proceeds from sales of assets (Note 8) $654.0m $1.1b $1.3b $77.0m $429.0m $881.0m $60.0m $328.0m $13.0m $81.0m
Proceeds from the issuance of related party notes (Note 17) $0 $629.0m $330.0m
Proceeds from the issuance of senior notes (Note 11) $748.0m $0 $0 $998.0m $748.0m $0 $650.0m $3.0b
Repayment under EPIC credit agreement (Note 11) ($92.0m) $0 $0 $0 ($1.1b)
Repayments of senior notes (Note 11) ($175.0m) ($1.4b) $0 ($1.0b) ($617.0m) ($750.0m) ($1.1b) ($750.0m) ($1.0b)
Repurchase of Series A preferred units (Note 12) $0 $0 ($333.0m)
Repurchase of common units (Note 12) $0 $0 ($50.0m) ($178.0m) ($74.0m) $0 $0 ($8.0m)
Settlement of terminated interest rate hedging instruments (Note 13) ($29.0m) ($29.0m) $14.0m ($55.0m) ($100.0m) $42.0m $80.0m $57.0m $37.0m
Trade accounts payable and other $501.0m $847.0m ($367.0m) $1.2b ($1.3b) $2.0b ($830.0m) ($242.0m) ($90.0m) ($334.0m)
Trade accounts receivable and other ($524.0m) ($511.0m) $309.0m ($1.2b) $1.4b ($2.2b) $649.0m $213.0m $94.0m $204.0m
Derivative, Gain (Loss) on Derivative, Net ($324.0m) ($198.0m) $106.0m $325.0m
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($8.0m)
Net Cash Provided by (Used in) Operating Activities $733.0m $2.5b $2.6b $2.5b $1.5b $2.0b $2.4b $2.7b $2.5b $2.9b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.3b $1.0b $1.6b $1.2b $738.0m $336.0m $455.0m $559.0m $619.0m $643.0m
Other investing activities ($3.0m) ($1.0m) ($10.0m) ($13.0m) $1.0m ($33.0m) $44.0m $1.0m $4.0m $0
Payments for (Proceeds from) Other Investing Activities $3.0m $1.0m $10.0m $13.0m ($1.0m) $33.0m ($44.0m) ($1.0m) ($4.0m) $0
Net Cash Provided by (Used in) Investing Activities ($1.3b) ($1.6b) ($813.0m) ($1.8b) ($1.1b) $386.0m ($526.0m) ($702.0m) ($1.5b) ($3.8b)
Cash flows from financing activities:
Payments for Repurchase of Common Stock $50.0m $178.0m $74.0m $8.0m
Contributions from noncontrolling interests $0 $128.0m $0 $1.0m $26.0m $106.0m $57.0m $75.0m
Proceeds from Noncontrolling Interests $128.0m $0 $106.0m $57.0m $75.0m
Other financing activities ($31.0m) ($5.0m) ($24.0m) ($62.0m) $41.0m ($179.0m) ($53.0m) ($93.0m) ($53.0m) ($84.0m)
Proceeds from (Payments for) Other Financing Activities ($31.0m) ($5.0m) ($24.0m) ($62.0m) $41.0m ($179.0m) ($53.0m) ($93.0m) ($53.0m) ($84.0m)
Net Cash Provided by (Used in) Financing Activities $563.0m ($943.0m) ($1.8b) ($720.0m) ($435.0m) ($2.0b) ($1.9b) ($2.0b) ($1.1b) $799.0m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($10.0m) $29.0m ($3.0m) ($8.0m) ($5.0m) ($3.0m) $49.0m ($11.0m) $14.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37.0m $66.0m $16.0m ($22.0m) $393.0m ($52.0m) $49.0m ($102.0m) ($20.0m)
Net increase/(decrease) in cash and cash equivalents and restricted cash ($10.0m) $29.0m $16.0m ($22.0m) $393.0m ($52.0m) $49.0m ($102.0m) ($20.0m)
Cash and cash equivalents and restricted cash, beginning of period $37.0m $66.0m $82.0m $60.0m $453.0m $401.0m $450.0m $348.0m $328.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($10.0m) $29.0m $82.0m $60.0m $453.0m $401.0m $450.0m $348.0m $328.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $450.0m $486.0m $400.0m $397.0m $428.0m $401.0m $393.0m $377.0m $381.0m $516.0m
Income Taxes Paid, Net $98.0m $50.0m $21.0m $136.0m $111.0m $76.0m $112.0m $69.0m $269.0m $98.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.